Vanda Pharmaceuticals Inc. ( VNDA) - Stock Earnings
VNDA Upcoming earnings
Estimated EPS and revenue columns are available to paid members.
| Date | EPS (actual / est.) | Revenue low (est.) | Revenue (actual / est.) | Revenue high (est.) |
|---|---|---|---|---|
| Nov. 4, 2026, midnight | — / — | — | — / — | — |
VNDA Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q4 | -141.2 million USD | 57.2 million USD |
| 2026Q1 | -48.6 million USD | 51.7 million USD |
| 2026Q2 | -62.5 million USD | 50.5 million USD |
| 2026Q4 Est. | — | — |
| 2027Q1 Est. | — | — |
| 2027Q2 Est. | — | — |
VNDA Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | 2.5 million USD | 192.6 million USD |
| 2024 | -18.9 million USD | 198.8 million USD |
| 2025 | -220.5 million USD | 216.1 million USD |
| 2026 Est. | — | — |
VNDA
Price: $4.03
52 week price:
Earnings Per Share: -4.70 USD
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 456204
Ebitda: -1.4 millionMarket Capitalization: 275.4 million